Cyclobenzaprine Hydrochloride (Flexeril)

Category:

  • Muscle relaxant

Description:

  • Centrally acting skeletal muscle relaxant

  Indications:

  • Skeletal muscle spasms associated with painful musculoskeletal conditions

  • Unlabeled use:

    • fibrositis syndrome: 10-40mg/day in divided doses

  Contraindications:

  • Concomitant administration with monoamine oxidase inhibitors (MAOI) or with 14 days post discontinuing MAOI use.

  • Acute recovery phase of myocardial infarction.

  • Patients with arrhythmias, heart block, or conduction disorders.

  • Patients with congestive heart failure.

  • Patients with hyperthyroidism.

 Precautions:

  • Pregnancy category B

  • Structurally related to tricyclic antidepressants.

  • Use with caution in patients with a history of urinary retention, closed-angle glaucoma and increased intraocular pressure due to possible anticholinergic effects.

  • Will impair higher order motor function, therefore use caution when operating machinery or automobiles.

  • Use for only short-term treatment (2-3 weeks).

  • Use with caution when administering with other CNS depressive medications.

  • Do not drink alcohol when using cyclobenzaprine.

  Adverse Reactions (Side Effects):

Central nervous system: drowsiness, dizziness, fatigue, blurred vision, headache, nervousness

Gastrointestinal: nausea, constipation, dyspepsia, unpleasant taste

Dry mouth

Dosage:

  • Administered orally (tablets, capsules, liquid) or rectally

  • Adult:

    • 20-40mg per day in divided doses (no greater than 60mg per day)

    • Do not use for periods greater than three weeks

    • Not recommended for children under 15 years old.

  • Fibrositis syndrome:

    • 10-40mg/day in divided doses

 

 

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

Approved for public release; Distribution is unlimited.

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.

Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates, LLC.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

© 2015, Brookside Associates, LLC. All rights reserved

Other Brookside Products

 

 

Advertise on this site